16:00 Tue 15 Apr 2025
Tate & Lyle PLC - Integration update and pre-close statement

Integration of CP Kelco on-track, Tate & Lyle operating as one combined business |
Tate & Lyle issues the following update on the CP Kelco integration and a pre-close statement for the year ended
Headlines
· Integration on-track, confident in synergy delivery, operating as one combined business from
· Tate & Lyle performed as expected in Q4 with 2025 financial year results to be in line with guidance
· CP Kelco trading well and will deliver over 90bps increase in EBITDA margin1,2 in year to
· Strong free cash flow with Net debt to EBITDA expected to be 2.2x at
· Capital Markets event for investors and analysts to be held in the first week of
"Notwithstanding the uncertain macroeconomic environment, we are confident in the medium-term growth potential of the business we have created and are focused on delivering the benefits of the combination with CP Kelco and accelerating topline growth. Our confidence in the growth opportunity ahead has been strengthened by the positive engagement we are seeing from customers in both our expanded portfolio and capabilities.
In line with our normal practice, we will provide an update on the business when we announce our full-year results on
Trading update
Tate & Lyle performed as expected in Q4 and for the year ended
CP Kelco continues to trade well and will deliver an increase in EBITDA margin1,2 of over 90bps in the year ended
CP Kelco integration
The integration is progressing well and as planned, with Tate & Lyle and CP Kelco operating as one combined business from
· People: The new organisation and leadership team are now established and, from
· Performance: We are confident in delivering the targeted run-rate cost synergies of
· Customers: The transition to the combined business has been executed well, and we are seeing positive engagement from customers to both our expanded portfolio and capabilities, reinforcing our confidence in the delivery of the identified revenue synergies of up to 10% of CP Kelco's revenue over the medium-term.
Balance sheet
Cash generation remains strong with cash conversion3 for the 2025 financial year exceeding 75%, in line with our long-term ambition. Net debt to EBITDA at
Capital Markets event
We will be hosting a Capital Markets event for investors and analysts on Tuesday
This will be followed by a site visit to our pectin facility and labs in Lille Skensved, near
---------------------------------------------------------------------------------
Notes
1. Adjusted EBITDA margin is a non-GAAP measure, see definition of non-GAAP measures on page 147 of the Tate & Lyle annual report for the year ended
2. Change in adjusted EBITDA margin is in constant currency and compares to the restated adjusted EBITDA for the year ended
3. Cash conversion is free cash flow before capital expenditure divided by adjusted EBITDA.
END
For more information contact Tate & Lyle PLC:
Mobile: +44 (0)7796 192 688
Mobile: +44 (0)7825 523 383
About Tate & Lyle:
Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.
Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.
Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 38 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes,...
FOR OUR FULL DISCLAIMER CLICK HERE